// App-Quantinova.ai

P327 : Comparison of adalimumab drug levels and drug survival in proactive vs reactive therapeutic drug monitoring

Researchers

Presenter

  • Shields, S

Principal Investigators

  • Dunlop, A

  • Barry, S

  • Galloway, P

  • Seenan, J.P

  • Macdonald, J

Medical Centers

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

  • University of Strathclyde, Department of Mathematics and Statistics, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Post-transplant diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved